Paper41398960
The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist.
Papavergi MT and 3 others. Mol Neurodegener, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist. Papers, record 41398960. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41398960
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Complement System Proteins | Major topic |
| Complement Activation | Major topic |
| Humans | |
| Animals | |
| Brain |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 NS136122 | NINDS NIH HHS | United States | R01NS136122 | PubMed |
Source NIH RePORTER
References448
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39871402 | Physical Exercise Decreases Complement-Mediated Synaptic Loss and Protects Against Cognitive Impairment by Inhibiting Microglial Tmem9-ATP6V0D1 in Alzheimer's Disease. | Aging Cell | 2025 | https://conductscience.org/library/papers/39871402 | PubMed |
| 2 | 26243271 | CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease. | Neuropsychopharmacology | 2016 | https://conductscience.org/library/papers/26243271 | PubMed |
| 3 | 27554295 | Mechanisms of inflammation-driven bacterial dysbiosis in the gut. | Mucosal Immunol | 2017 | https://conductscience.org/library/papers/27554295 | PubMed |
| 4 | 24038819 | Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies. | Am J Med Genet B Neuropsychiatr Genet | 2013 | https://conductscience.org/library/papers/24038819 | PubMed |
| 5 | 37865470 | Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. | Lancet | 2023 | https://conductscience.org/library/papers/37865470 | PubMed |
| 6 | 33423792 | Blood-Brain Barrier Dynamics to Maintain Brain Homeostasis. | Trends Neurosci | 2021 | https://conductscience.org/library/papers/33423792 | PubMed |
| 7 | 31060348 | miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q. | Eur J Histochem | 2019 | https://conductscience.org/library/papers/31060348 | PubMed |
| 8 | 29134267 | Complement in the pathogenesis of Alzheimer's disease. | Semin Immunopathol | 2018 | https://conductscience.org/library/papers/29134267 | PubMed |
| 9 | 29051531 | Gut microbiome alterations in Alzheimer's disease. | Sci Rep | 2017 | https://conductscience.org/library/papers/29051531 | PubMed |
| 10 | 25727254 | Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. | Ann Neurol | 2015 | https://conductscience.org/library/papers/25727254 | PubMed |
| 11 | 17942002 | Molecular evolution of the human SRPX2 gene that causes brain disorders of the Rolandic and Sylvian speech areas. | BMC Genet | 2007 | https://conductscience.org/library/papers/17942002 | PubMed |
| 12 | 39009837 | A clinical perspective on the revised criteria for diagnosis and staging of Alzheimer's disease. | Nat Aging | 2024 | https://conductscience.org/library/papers/39009837 | PubMed |
| 13 | 24566914 | Intestinal epithelial cells: regulators of barrier function and immune homeostasis. | Nat Rev Immunol | 2014 | https://conductscience.org/library/papers/24566914 | PubMed |
| 14 | 39789340 | Human iPSC-derived microglial cells protect neurons from neurodegeneration in long-term cultured adhesion brain organoids. | Commun Biol | 2025 | https://conductscience.org/library/papers/39789340 | PubMed |
| 15 | 39147742 | C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer's disease mouse model. | Nat Commun | 2024 | https://conductscience.org/library/papers/39147742 | PubMed |
| 16 | 40050704 | Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease. | Nat Med | 2025 | https://conductscience.org/library/papers/40050704 | PubMed |
| 17 | 35336153 | Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. | Microorganisms | 2022 | https://conductscience.org/library/papers/35336153 | PubMed |
| 18 | 22244847 | Alzheimer's disease risk factor complement receptor 1 is associated with depression. | Neurosci Lett | 2012 | https://conductscience.org/library/papers/22244847 | PubMed |
| 19 | 23482636 | Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase. | FASEB J | 2013 | https://conductscience.org/library/papers/23482636 | PubMed |
| 20 | 18801740 | An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18801740 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42918974 | Gut-brain axis in Alzheimer's disease: neuroinflammatory mechanisms and immunopharmacological interventions. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42918974 | PubMed |
| 42877317 | Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/42877317 | PubMed |
| 42796561 | Small-Molecule NANT Therapeutics Targeting the Brain-Immune Axis in Alzheimer's Disease: Mechanisms, Clinical Progress, and Translational Challenges. | Molecules | 2026 | https://conductscience.org/library/papers/42796561 | PubMed |
| 42712875 | Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease. | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42712875 | PubMed |
| 42667495 | Integrative transcriptomics identifies shared aging-associated inhibitory-neuron states and prioritizes RGL2 across postoperative delirium and Alzheimer's disease. | J Mol Neurosci | 2026 | https://conductscience.org/library/papers/42667495 | PubMed |
| 42363270 | Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42363270 | PubMed |
| 42337797 | The complement system in Alzheimer's disease: evaluating biomarker potential in a complex neuroimmune context. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42337797 | PubMed |
| 42064068 | The complement system in Alzheimer's disease: mechanisms, biomarkers, and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42064068 | PubMed |
| 41867862 | Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice. | bioRxiv | 2026 | https://conductscience.org/library/papers/41867862 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41398960
GET https://conductscience.org/api/papers/v1/41398960/references?page=2